The Strategy Engine and full autonomous platform are scheduled for release to retail investors in Q2 2026. About Option Circle: ...
Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.